Formosa Laboratories (4746) Stock Overview

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers worldwide. It offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, antibiotics, potassium binders, and other areas. The company also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. In addition, it is involved in chemical trading; investment; and wholesale of chemical raw materials and products, as well as commission agency activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan, Taiwan.